Lv5
835 积分 2020-11-07 加入
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
13天前
已关闭
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
13天前
已完结
Blinatumomab in refractory SLE-associated immune thrombocytopenia
13天前
已完结
Blinatumomab in refractory SLE-associated immune thrombocytopenia
13天前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
2个月前
已完结
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
2个月前
已完结
Do Patients With NASH-related Cirrhosis Have Better Overall Survival Compared With Other Etiologies of Cirrhosis? A Population-based Study
2个月前
已完结
Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease
2个月前
已完结
Seborrheic Dermatitis in the Geriatric Population
2个月前
已完结
Relationship of non-invasive measures with histological response in patients with nonalcoholic steatohepatitis and fibrosis: 52-week data from the Phase 3 MAESTRO-NASH trial
2个月前
已完结
皖公网安备34019202002308
